CN Patent

CN106470704A — 药物剂型

Assigned to Recordati SA · Expires 2017-03-01 · 9y expired

What this patent protects

本发明涉及口服的药物剂型及制备所述固体药物剂型的方法，所述药物剂型包含药物成分4‑[(5R)‑6,7‑二氢‑5H‑吡咯并[1,2‑c]咪唑‑5‑基]‑3‑氟苯甲腈或其任何药学上可接受的盐。

USPTO Abstract

本发明涉及口服的药物剂型及制备所述固体药物剂型的方法，所述药物剂型包含药物成分4‑[(5R)‑6,7‑二氢‑5H‑吡咯并[1,2‑c]咪唑‑5‑基]‑3‑氟苯甲腈或其任何药学上可接受的盐。

Drugs covered by this patent

osilodrostat-phosphate (OSILODROSTAT PHOSPHATE)

Patent Metadata

Patent number: CN106470704A
Jurisdiction: CN
Classification: —
Expires: 2017-03-01
Drug substance claim: No
Drug product claim: No
Assignee: Recordati SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.